SYHX1901
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SYHX1901, covering 2024-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 3]